Thromboelastography to Study Burn Coagulopathy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFrancesco Egro

About this trial

This pilot study examines the use of thromboelastography (TEG), a specialized blood test, to evaluate clotting abnormalities in burn patients. The study aims to understand how burn injuries impact the body's ability to form and break down blood clots over time. Specifically, the investigators will research whether the percentage of total body surface area burned (%TBSA) is associated with changes in blood clotting, track the evolution of clotting patterns during the first four weeks following a burn injury, and explore whether these changes can predict recovery or complications. By providing new insights into clotting dynamics in burn patients, the study seeks to improve diagnostic methods, enhance monitoring strategies, and guide treatments to optimize patient care and outcomes.

Eligibility criteria

Qualifiers

Patients admitted with acute burn injuries

Aged 18 years and older

Provided consent to participate in the study

Disqualifiers

Patients with a history of venous thromboembolism or hyper/hypocoagulopathy

Trial design

Treatments tested in this trial

  • Thromboelastography

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

Francesco Egro

Lead sponsor

University of Pittsburgh

Sponsor institution